Obesity drug pipeline not so fat.
Gura
Trisha
T
D054369:Agouti-Related Protein; D000818:Animals; D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001066:Appetite / Q000187:drug effects; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism; D020934:Ciliary Neurotrophic Factor / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003503:Cyclobutanes / Q000009:adverse effects / Q000627:therapeutic use; D002149:Energy Intake; D054439:Ghrelin; D006801:Humans; D006815:Hunger / Q000187:drug effects; D036341:Intercellular Signaling Peptides and Proteins; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use; D020738:Leptin / Q000378:metabolism / Q000627:therapeutic use; D051379:Mice; D009419:Nerve Tissue Proteins / Q000009:adverse effects / Q000627:therapeutic use; D009474:Neurons / Q000378:metabolism; D009478:Neuropeptide Y / Q000378:metabolism / Q000494:pharmacology; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism; D000077403:Orlistat; D010446:Peptide Fragments; D036361:Peptide Hormones / Q000378:metabolism / Q000494:pharmacology; D019894:Peptide YY / Q000378:metabolism / Q000494:pharmacology; D010645:Phentermine / Q000009:adverse effects / Q000627:therapeutic use; D011506:Proteins / Q000378:metabolism; D018043:Receptors, Corticotropin / Q000378:metabolism; D044101:Receptors, Melanocortin; D015431:Weight Loss; D000521:alpha-MSH / Q000378:metabolism
D054369:Agouti-Related Protein; D019440:Anti-Obesity Agents; D020934:Ciliary Neurotrophic Factor; D003503:Cyclobutanes; D054439:Ghrelin; D036341:Intercellular Signaling Peptides and Proteins; D007783:Lactones; D020738:Leptin; D009419:Nerve Tissue Proteins; D009478:Neuropeptide Y; D010446:Peptide Fragments; D036361:Peptide Hormones; D011506:Proteins; D018043:Receptors, Corticotropin; D044101:Receptors, Melanocortin; D019894:Peptide YY; C061785:peptide YY (3-36); D000521:alpha-MSH; D000077403:Orlistat; C118937:axokine; D010645:Phentermine; C058254:sibutramine